Therefore, to further explore the pathway through which CTLA4 potentially affects CLL pathogenesis, we performed microarray analyses to investigate the transcript levels of molecules associated with the BCR signaling pathway in CLL in high- and low-CTLA4 groups (Figure 3-IA). Here, CTLA4 is linked to B-cell chronic lymphocytic leukemia.